Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109687065 | 10968706 | 5 | F | 201410 | 20160914 | 20150330 | 20160919 | EXP | CA-ROCHE-1471588 | ROCHE | 27.89 | YR | M | Y | 0.00000 | 20160919 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109687065 | 10968706 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | D | UNKNOWN | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 109687065 | 10968706 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | FREQUENCY: EVERY OTHER WEEK, TEMPORARILY DISCONTINUED, LAST DOSE WAS TAKEN ON 17/OCT/2014 | D | UNKNOWN | 125472 | 162 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | QOW | ||||
| 109687065 | 10968706 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Subcutaneous | STOPPED IN MID OF DEC/2014 | D | UNKNOWN | 125472 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||
| 109687065 | 10968706 | 4 | C | ARAVA | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 6 | C | OMNARIS | CICLESONIDE | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 7 | C | XELJANZ | TOFACITINIB CITRATE | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 8 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 9 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 11 | C | MORPHINE | MORPHINE | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 12 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 109687065 | 10968706 | 13 | C | NAPROXEN. | NAPROXEN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109687065 | 10968706 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109687065 | 10968706 | HO |
| 109687065 | 10968706 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109687065 | 10968706 | Chest pain | |
| 109687065 | 10968706 | Dyspnoea | |
| 109687065 | 10968706 | Frustration tolerance decreased | |
| 109687065 | 10968706 | Headache | |
| 109687065 | 10968706 | Hepatic enzyme abnormal | |
| 109687065 | 10968706 | Hyperlipidaemia | |
| 109687065 | 10968706 | Infection | |
| 109687065 | 10968706 | Injection site cyst | |
| 109687065 | 10968706 | Joint swelling | |
| 109687065 | 10968706 | Nausea | |
| 109687065 | 10968706 | Pain in jaw | |
| 109687065 | 10968706 | Sinusitis | |
| 109687065 | 10968706 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109687065 | 10968706 | 1 | 20140926 | 0 | ||
| 109687065 | 10968706 | 2 | 20141017 | 0 | ||
| 109687065 | 10968706 | 3 | 201412 | 0 |